Glynib (Imatinib Mesylate) 100 mg: Availability, Uses, and Considerations in Pakistan
Glynib, which contains the active substance imatinib mesylate, is an important medication primarily utilized in the treatment of specific forms of cancer, notably chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). As an inhibitor of the BCR-ABL protein, Glynib effectively targets and disrupts the signaling pathways that promote the growth and survival of cancerous…